Womed has raised $8.0M in a new funding round, with backing from IRDI Capital Investissement, CEMAG, and Cantrak.
The company is developing intrauterine therapies aimed at treating infertility, uterine bleeding, and endometriosis - a mission it describes as transforming women's health while respecting the integrity of women's bodies.
















